Restera
Total Raised
$55.85MInvestors Count
8Deal Terms
2Funding, Valuation & Revenue
6 Fundings
Restera has raised $55.85M over 6 rounds.
Restera's latest funding round was a Incubator/Accelerator for on May 29, 2024.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
5/29/2024 | Incubator/Accelerator | 1 | ||||
10/14/2022 | Unattributed VC - II | |||||
11/15/2021 | Unattributed VC | |||||
1/2/2018 | Series B | |||||
7/12/2016 | Series A |
Date | 5/29/2024 | 10/14/2022 | 11/15/2021 | 1/2/2018 | 7/12/2016 |
|---|---|---|---|---|---|
Round | Incubator/Accelerator | Unattributed VC - II | Unattributed VC | Series B | Series A |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
Restera Deal Terms
2 Deal Terms
Restera's deal structure is available for 2 funding rounds, including their Series B from January 02, 2018.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Restera Investors
8 Investors
Restera has 8 investors. MedTech Innovator invested in Restera's Incubator/Accelerator funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
5/29/2024 | 5/29/2024 | 1 Incubator/Accelerator | Incubator/Accelerator | California | ||
Venture Capital | California | |||||
Venture Capital | California | |||||
Venture Capital | California | |||||
Venture Capital | California |
First funding | 5/29/2024 | ||||
|---|---|---|---|---|---|
Last Funding | 5/29/2024 | ||||
Investor | |||||
Rounds | 1 Incubator/Accelerator | ||||
Board Seats | |||||
Type | Incubator/Accelerator | Venture Capital | Venture Capital | Venture Capital | Venture Capital |
Location | California | California | California | California | California |
Compare Restera to Competitors
Hilo operates within the medical device industry. The company offers a cuffless, artificial intelligence (AI) powered blood pressure monitor that enables continuous monitoring for users and healthcare professionals. Hilo's technology is based on research and development, utilizing a large dataset for blood pressure management. Hilo was formerly known as Aktiia. It was founded in 2018 and is based in Neuchatel, Switzerland.
BioSerenity develops connected medical solutions for the healthcare sector, focusing on neurology, sleep disorders, and cardiology. The company provides medical devices, artificial intelligence, and software that assist hospitals in performing EEGs and diagnosing sleep disorders. BioSerenity serves the healthcare industry with tools for chronic disease management and remote patient monitoring. It was founded in 2014 and is based in Paris, France.
Element Science specializes in medical devices and digital health, focusing on solutions to prevent sudden cardiac arrest. Their product, the Jewel4 Patch Wearable Cardioverter Defibrillator, provides monitoring and response to cardiac emergencies. The company serves the healthcare sector with a mission to improve patient safety. Element Science was formerly known as Revive Defibrillation Systems. It was founded in 2011 and is based in San Francisco, California.
Hexoskin focuses on smart clothing and wearable technology for health monitoring in the healthcare and fitness sectors. The company provides garments with sensors that track biometric data, including cardiac, respiratory, and activity metrics, which are analyzed through their health monitoring platform. Hexoskin's products are used in healthcare research, clinical development, sports analysis, and by defense and first responder personnel for monitoring. It was founded in 2006 and is based in Montreal, Quebec.
VitalConnect develops wearable biosensor technology for the healthcare sector. The company provides products for cardiac monitoring and patient monitoring in both hospital and home settings. Its products are used in inpatient and outpatient care, as well as in pharmaceutical applications. VitalConnect was formerly known as Vigilo Networks. It was founded in 2011 and is based in San Jose, California.
L.I.F.E. is a company focused on telehealth solutions and medically certified wearable devices within the healthcare technology sector. The company offers products that enable remote diagnostic monitoring and analysis of physiological data with medical precision. L.I.F.E.'s wearable devices are designed to improve health, modify habits, enhance performance, and optimize efficiency in daily life. It was founded in 2012 and is based in Milan, Italy.
Loading...